Advertisement

Can effusion-synovitis measured on ultrasound or MRI predict response to intra-articular steroid injection in hip osteoarthritis?

  • K. J. D. Steer
  • G. P. Bostick
  • L. J. Woodhouse
  • T. T. Nguyen
  • A. Schankath
  • R. G. W. Lambert
  • J. L. Jaremko
Scientific Article
  • 29 Downloads

Abstract

Objectives

Intra-articular steroid injection (IASI) is an effective therapy for hip osteoarthritis (OA), but carries risks and provides significant pain relief to only two thirds of patients. We attempted to predict response to IASI in hip OA patients using baseline clinical, ultrasound, and MRI data.

Methods

Observational study of 97 subjects with symptomatic hip OA presenting for IASI. At baseline and 8 weeks we obtained hip MRI, grayscale and Doppler ultrasound, clinical range of motion (ROM), timed-up and go test (TUG) scores, and self-reported Western Ontario and McMaster Universities Osteoarthritis (WOMAC) pain, stiffness, and function scores. Bone-capsule distance (BCD) measurements of inflammation on hip ultrasound and MRI were measured at three locations: the proximal-most uncovered portion of the femoral head, the superficial-most (apex) portion of the femoral head, and the largest fluid pocket at the femoral neck.

Results

Ultrasound and MRI BCD correlated with each other significantly and strongly at the apex and neck. Power Doppler findings did not correlate significantly with any other imaging indices. Eight weeks post-injection, WOMAC pain, function, and stiffness scores significantly improved and TUG time improved nearly to the level of significance, but there were no significant changes in ultrasound, MRI, or Doppler indices. Baseline variables were not significantly different between responder and nonresponder WOMAC pain or TUG time cohorts.

Conclusion

Basic measures of inflammation on ultrasound and MRI are highly related to each other, but provide little insight into patient function and pain after IASI. Other mechanisms to explain improvement in patient status after IASI are likely at work.

Keywords

Osteoarthritis Corticosteroids Ultrasonography Magnetic resonance imaging 

Notes

Acknowledgements

This manuscript was part of a large project involving members of multiple specialties, all of whom were integral to the creation of this manuscript. We would like to specifically thank Joanne McGoey, Benjamin RK Smith, Omar Azmat, and Lawrence D Stillwater for their essential contributions.

Funding support

Capital Health Chair in Diagnostic Imaging.

Compliance with ethical standards

Conflicts of interest

Kieran JD Steer has received funding from the Northern Alberta Clinical Trials and Research Centre. Robert GW Lambert has received funding from AbbVie, BioClinica, Parexel, UCB. Linda J Woodhouse has received funding from Alberta Health Services, American Physical Therapy Association (APTA), Focus of Therapeutic Outcomes (FOTO), Eli Lilly, Scholar Rock Inc., and Canadian Physiotherapy Association (CPA). Dr. Jaremko is supported by the Capital Health Endowed Chair in Diagnostic Imaging.

Supplementary material

256_2018_3010_MOESM1_ESM.docx (34 kb)
ESM 1 (DOCX 34 kb)

References

  1. 1.
    Altman R, Alarcon G, Appelrouth D, Bloch D, Borenstein D, Brandt K, et al. The American College of Rheumatology criteria for the classification and reporting of osteoarthritis of the hip. Arthritis Rheum. 1991;34(5):505–14.CrossRefPubMedGoogle Scholar
  2. 2.
    Plotnikoff R, Karunamuni N, Lytvyak E, Penfold C, Schopflocher D, Imayama I, et al. Osteoarthritis prevalence and modifiable factors: a population study. BMC Public Health. 2015;15:1195.CrossRefPubMedPubMedCentralGoogle Scholar
  3. 3.
    Allen KD, Bosworth HB, Chatterjee R, Coffman CJ, Corsino L, Jeffreys AS, et al. Clinic variation in recruitment metrics, patient characteristics and treatment use in a randomized clinical trial of osteoarthritis management. BMC Musculoskelet Disord. 2014;15:413.CrossRefPubMedPubMedCentralGoogle Scholar
  4. 4.
    Eyles JP, Mills K, Lucas BR, Williams MJ, Makovey J, Teoh L, et al. Can we predict those with osteoarthritis who will worsen following a chronic disease management program? Arthritis Care Res. 2016;68(9):1268–77.CrossRefGoogle Scholar
  5. 5.
    McCabe PS, Maricar N, Parkes MJ, Felson DT, O’Neill TW. The efficacy of intra-articular steroids in hip osteoarthritis: a systematic review. Osteoarthritis Cartilage. 2016;24(9):1509–17.CrossRefPubMedGoogle Scholar
  6. 6.
    Van Middelkoop M, Arden NK, Atchia I, Birrell F, Chao J, Rezende MU, et al. The OA trial bank: meta-analysis of individual patient data from knee and hip osteoarthritis trials show that patients with severe pain exhibit greater benefit from intra-articular glucocorticoids. Osteoarthritis Cartilage. 2016;24(7):1143–52.CrossRefPubMedGoogle Scholar
  7. 7.
    Qvistgaard E, Christensen R, Torp-Pedersen S, Bliddal H. Intra-articular treatment of hip osteoarthritis: a randomized trial of hyaluronic acid, corticosteroid, and isotonic saline. Osteoarthritis Cartilage. 2006;14(2):163–70.CrossRefPubMedGoogle Scholar
  8. 8.
    Park KD, Kim TK, Bae BW, Ahn J, Lee WY, Park Y. Ultrasound guided intra-articular ketorolac versus corticosteroid injection in osteoarthritis of the hip: a retrospective comparative study. Skeletal Radiol. 2015;44(9):1333–40.CrossRefPubMedGoogle Scholar
  9. 9.
    Habib GS, Saliba W, Nashashibi M. Local effects of intra-articular corticosteroids. Clin Rheumatol. 2010;29(4):347–56.CrossRefPubMedGoogle Scholar
  10. 10.
    Chambers AW, Lacy KW, Liow MHL, Manalo JPM, Freiberg AA, Kwon YM. Multiple hip intra-articular steroid injections increase risk of periprosthetic joint infection compared with single injections. J Arthroplast. 2017;32(6):1980–3.CrossRefGoogle Scholar
  11. 11.
    Xing D, Yang Y, Ma X, Ma J, Ma B, Chen Y. Dose intraarticular steroid injection increase the rate of infection in subsequent arthroplasty: grading the evidence through a meta-analysis. J Orthop Surg Res. 2014;9:107.CrossRefPubMedPubMedCentralGoogle Scholar
  12. 12.
    Chong T, Don DW, Kao MC, Wong D, Mitra R. The value of physical examination in the diagnosis of hip osteoarthritis. J Back Musculoskelet Rehabil. 2013;26(4):397–400.CrossRefPubMedGoogle Scholar
  13. 13.
    Plant MJ, Borg AA, Dziedzic K, Saklatvala J, Dawes PT. Radiographic patterns and response to corticosteroid hip injection. Ann Rheum Dis. 1997;56(8):476–80.CrossRefPubMedPubMedCentralGoogle Scholar
  14. 14.
    Robinson P, Keenan AM, Conaghan PG. Clinical effectiveness and dose response of image-guided intra-articular corticosteroid injection for hip osteoarthritis. Rheumatology (Oxford). 2007;46(2):285–91.CrossRefGoogle Scholar
  15. 15.
    Sudula SN. Imaging the hip joint in osteoarthritis: a place for ultrasound? Ultrasound. 2016;24(2):111–8.CrossRefPubMedPubMedCentralGoogle Scholar
  16. 16.
    Blum A, Raymond A, Teixeira P. Strategy and optimization of diagnostic imaging in painful hip in adults. Orthop Traumatol Surg Res. 2015;101(1 Suppl):S85–99.CrossRefPubMedGoogle Scholar
  17. 17.
    Qvistgaard E, Torp-Pedersen S, Christensen R, Bliddal H. Reproducibility and inter-reader agreement of a scoring system for ultrasound evaluation of hip osteoarthritis. Ann Rheum Dis. 2006;65(12):1613–9.CrossRefPubMedPubMedCentralGoogle Scholar
  18. 18.
    Micu MC, Bogdan GD, Fodor D. Steroid injection for hip osteoarthritis: efficacy under ultrasound guidance. Rheumatology (Oxford). 2010;49(8):1490–4.CrossRefGoogle Scholar
  19. 19.
    Atchia I, Kane D, Reed MR, Isaacs JD, Birrell F. Efficacy of a single ultrasound-guided injection for the treatment of hip osteoarthritis. Ann Rheum Dis. 2011;70(1):110–6.CrossRefPubMedGoogle Scholar
  20. 20.
    Koski JM, Anttila P, Hamalainen M, Isomaki H. Hip joint ultrasonography: correlation with intra-articular effusion and synovitis. Br J Rheumatol. 1990;29(3):189–92.CrossRefPubMedGoogle Scholar
  21. 21.
    Bierma-Zeinstra SM, Bohnen AM, Verhaar JA, Prins A, Ginai-Karamat AZ, Lameris JS. Sonography for hip joint effusion in adults with hip pain. Ann Rheum Dis. 2000;59(3):178–82.CrossRefPubMedPubMedCentralGoogle Scholar
  22. 22.
    Jaremko JL, Azmat O, Lambert RGW, Bird P, Haugen IK, Jans L, et al. Validation of a knowledge transfer tool according to the OMERACT filter: does web-based real-time iterative calibration enhance the evaluation of bone marrow lesions in hip osteoarthritis? J Rheumatol. 2017;44(11):1713–7.CrossRefPubMedGoogle Scholar
  23. 23.
    Kersten P, White PJ, Tennant A. The visual analogue WOMAC 3.0 scale—internal validity and responsiveness of the VAS version. BMC Musculoskelet Disord. 2010;11:80.CrossRefPubMedPubMedCentralGoogle Scholar
  24. 24.
    Bellamy N, Buchanan WW, Goldsmith CH, Campbell J, Stitt LW. Validation study of WOMAC: a health status instrument for measuring clinically-important patient-relevant outcomes following total hip or knee arthroplasty in osteoarthritis. J Orthop Rheumatol. 1988;1:95–108.Google Scholar
  25. 25.
    Kennedy D, Stratford PW, Pagura SM, Walsh M, Woodhouse LJ. Comparison of gender and group differences in self-report and physical performance measures in total hip and knee arthroplasty candidates. J Arthroplast. 2002;17(1):70–7.CrossRefGoogle Scholar
  26. 26.
    Kellgren JH, Lawrence JS. Radiological assessment of osteo-arthrosis. Ann Rheum Dis. 1957;16(4):494–502.CrossRefPubMedPubMedCentralGoogle Scholar
  27. 27.
    Lambert RG, Hutchings EJ, Grace MG, Jhangri GS, Conner-Spady B, Maksymowych WP. Steroid injection for osteoarthritis of the hip: a randomized, double-blind, placebo-controlled trial. Arthritis Rheum. 2007;56(7):2278–87.CrossRefPubMedGoogle Scholar
  28. 28.
    Kim C, Linsenmeyer KD, Vlad SC, Guermazi A, Clancy MM, Niu J, et al. Prevalence of radiographic and symptomatic hip osteoarthritis in an urban United States community: the Framingham osteoarthritis study. Arthritis Rheumatol. 2014;66(11):3013–7.CrossRefPubMedPubMedCentralGoogle Scholar
  29. 29.
    Spolidoro Paschoal NO, Natour J, Machado FS, Alcantara Veiga de Oliveira H, Vilar Furtado RN. Interphalangeal joint sonography of symptomatic hand osteoarthritis: clinical and functional correlation. J Ultrasound Med. 2017;36(2):311–9.CrossRefPubMedGoogle Scholar
  30. 30.
    Pua YH, Wrigley TV, Collins M, Cowan SM, Bennell KL. Association of physical performance with muscle strength and hip range of motion in hip osteoarthritis. Arthritis Rheum. 2009;61(4):442–50.CrossRefPubMedGoogle Scholar
  31. 31.
    Iagnocco A, Filippucci E, Riente L, Meenagh G, Delle Sedie A, Sakellariu G, et al. Ultrasound imaging for the rheumatologist XLI. Sonographic assessment of the hip in OA patients. Clin Exp Rheumatol. 2012;30(5):652–7.PubMedGoogle Scholar
  32. 32.
    Tormenta S, Sconfienza LM, Iannessi F, Bizzi E, Massafra U, Orlandi D, et al. Prevalence study of iliopsoas bursitis in a cohort of 860 patients affected by symptomatic hip osteoarthritis. Ultrasound Med Biol. 2012;38(8):1352–6.CrossRefPubMedGoogle Scholar
  33. 33.
    Birn J, Pruente R, Avram R, Eyler W, Mahan M, van Holsbeeck M. Sonographic evaluation of hip joint effusion in osteoarthritis with correlation to radiographic findings. J Clin Ultrasound. 2014;42(4):205–11.CrossRefPubMedGoogle Scholar

Copyright information

© ISS 2018

Authors and Affiliations

  • K. J. D. Steer
    • 1
  • G. P. Bostick
    • 2
  • L. J. Woodhouse
    • 2
    • 3
  • T. T. Nguyen
    • 1
  • A. Schankath
    • 1
  • R. G. W. Lambert
    • 1
  • J. L. Jaremko
    • 1
  1. 1.Department of Radiology and Diagnostic Imaging, Faculty of MedicineUniversity of AlbertaEdmontonCanada
  2. 2.Department of Physical Therapy, Faculty of Rehabilitation MedicineUniversity of AlbertaEdmontonCanada
  3. 3.McCaig Institute for Bone and Joint HealthCalgaryCanada

Personalised recommendations